{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T17:59:36Z","timestamp":1768154376435,"version":"3.49.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082775","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T21:36:56Z","timestamp":1388525816000},"page":"e82775","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Effect of Statins on Mortality in Septic Patients: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1371","volume":"8","author":[{"given":"Laura","family":"Pasin","sequence":"first","affiliation":[]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[]},{"given":"Maria Lourdes","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Luca","family":"Cabrini","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Belletti","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Feltracco","sequence":"additional","affiliation":[]},{"given":"Gabriele","family":"Finco","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Carozzo","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Chiesa","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Zangrillo","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA inhibitors","volume":"33","author":"A Endo","year":"1992","journal-title":"J Lipid Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: results of the Cholesterol and Recurrent Events (CARE) trial","volume":"335","author":"FM Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"ref3","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"PM Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"PM Ridker","year":"2009","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1469-0691.2009.02750.x","article-title":"Statins for sepsis: a critical and updated review","volume":"15","author":"P Kopterides","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","article-title":"Statins and cancer: A systematic review and meta-analysis","volume":"44","author":"J Kuoppala","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","article-title":"The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis","volume":"203","author":"A Blum","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"MK Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"B Kwak","year":"2000","journal-title":"Nat Med"},{"issue":"14","key":"ref11","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/01.CIR.0000158665.27783.0C","article-title":"Simvastatin blunts endotoxin-induced tissue factor in vivo","volume":"111","author":"S Steiner","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001721-200309000-00010","article-title":"Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation","volume":"14","author":"J Shi","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"S Youssef","year":"2002","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2007-08-106005","article-title":"Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity","volume":"110","author":"R Zeiser","year":"2007","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biopha.2010.12.005","article-title":"The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray","volume":"65","author":"Y Wang","year":"2011","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1164\/rccm.201006-0955OC","article-title":"Continuation of statin therapy in patients with presumed infection: a randomized controlled trial","volume":"183","author":"PS Kruger","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","article-title":"The ANZ- STATInS Investigators - ANZICS Clinical Trials Group. A Multicentre Randomised Trial of Atorvastatin Therapy in Intensive Care Patients with Severe Sepsis","volume":"187","author":"P Kruger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc11895","article-title":"Randomized double-blind placebo-controlled trial of 40 mg\/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)","volume":"16","author":"JM Patel","year":"2012","journal-title":"Crit Care"},{"key":"ref19","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cochranehandbook.org\" xlink:type=\"simple\">http:\/\/www.cochranehandbook.org<\/ext-link>. Accessed: July 2012."},{"key":"ref20","first-page":"161","article-title":"The rough guide to systematic reviews and meta-analyses","volume":"3","author":"G Biondi-Zoccai","year":"2011","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"issue":"2","key":"ref21","first-page":"93","article-title":"A journey into clinical evidence: from case report to mixed treatment comparisons","volume":"3","author":"G Biondi-Zoccai","year":"2011","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.athoracsur.2012.11.071","article-title":"Statin therapy is associated with fewer infections after cardiac operations","volume":"95","author":"M Trezzi","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2011.02.005","article-title":"Effects of simvastatin on cytokines secretion from mononuclear cells from critically ill patients with acute kidney injury","volume":"54","author":"GL Ferrari","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1553-2712.2009.00350.x","article-title":"Statin therapy is associated with decreased mortality in patients with infection","volume":"16","author":"MW Donnino","year":"2009","journal-title":"Acad Emerg Med"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/STROKEAHA.106.475905","article-title":"Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage","volume":"38","author":"MY Tseng","year":"2007","journal-title":"Stroke"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/CCM.0b013e318225742c","article-title":"Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study","volume":"39","author":"D Makris","year":"2011","journal-title":"Crit Care Med"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","article-title":"A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study)","volume":"183","author":"TR Craig","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00134-011-2247-8","article-title":"Effect of statin therapy on plasma adiponectin concentrations in patients with the sepsis syndrome: a preliminary investigation","volume":"37","author":"K Robinson","year":"2011","journal-title":"Intensive Care Med"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00134-009-1429-0","article-title":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial","volume":"35","author":"V Novack","year":"2009","journal-title":"Intensive Care Med"},{"key":"ref31","unstructured":"Choi HS, Park MJ, Kang HM, Kim YJ, Choi CW, <etal>et al<\/etal>.. (2008) Statin use in sepsis due to pneumonia. Poster #920. Presented May 16\u201318, 2008 International Conference, Toronto, Canada."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)39169-4","article-title":"Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis","volume":"294","author":"H Ando","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.104.502195","article-title":"Statin treatment after onset of sepsis in a murine model improves survival","volume":"112","author":"MW Merx","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"656.e7","DOI":"10.1016\/j.jcrc.2010.02.013","article-title":"The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis","volume":"25","author":"S Janda","year":"2010","journal-title":"J Crit Care"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjmed.2012.04.011","article-title":"Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis","volume":"125","author":"V Chopra","year":"2012","journal-title":"Am J Med"},{"key":"ref36","unstructured":"Stagnitti MN (2008) Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005. In Medical Expenditure Panel Survey: Statistical Brief #205. Edited by Agency for Healthcare Research and Quality. Rockville: Agency for Healthcare Research and Quality."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"RS Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"J Armitage","year":"2007","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:23:35Z","timestamp":1746095015000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082775"}},"subtitle":[],"editor":[{"given":"Emmanuel A.","family":"Burdmann","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082775","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}